Skip to content

Nalu Medical, Inc. 12001-040-USRecalls & reported problems

Nalu Medical, Inc. · Lead (8 contact, 40 cm) · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00812537033792), received between Aug 2, 2023 and Aug 2, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Migration1

Patient problems

  • Inadequate Pain Relief1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 2, 2023Migration; Migration

    PATIENT WAS IMPLANTED WITH THE NALU PERIPHERAL NERVE STIMULATOR SYSTEM ON (B)(6) 2021. AFTER IMPLANT THE PATIENT SUSTAINED A FALL AND SUBSEQENTLY REPORTED LOSS OF PAIN RELIEF. XRAY IMAGING DETERMINED THAT THE IMPLANTED LEADS HAD MIGRATED AWAY FROM THE TARGET AREA FOR PAIN RELIEF. SURGICAL REVISION WAS PERFORMED ON (B)(6) 2022 IN WHICH THE IMPLANTABLE PULSE GENERATOR (IPG) AND IMPLANTED LEADS WERE REPLACED AND REPOSITIONED TO THE TARGET AREA FOR PAIN THERAPY.

    Patient problems: Inadequate Pain Relief

    MAUDE report 17445884 ↗

Other Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices

All Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page